Champions Oncology OverviewLatest common stock for CSBR: $14K.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Champions Oncology's common stock stands at $14K as of April 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Champions Oncology reported $14K in common stock versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
In the prior-year period, the figure was $0. Sustained growth in common stock can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how Champions Oncology's common stock evolved across reporting periods, while the comparison chart places CSBR next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, common stock is commonly used to spot outliers. Champions Oncology's reading of $14K is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.
